Preferred Name | cabazitaxel | |
Synonyms |
kabazitaxel 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate Jevtana |
|
ID |
http://purl.bioontology.org/ontology/MESH/C552428 |
|
altLabel |
kabazitaxel 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate Jevtana |
|
cui |
C2830183 C2927159 |
|
HM |
D043823 |
|
Inverse of RB |
51F690397J |
|
Mapped to | ||
MDA |
20101003 |
|
MeSH Frequency |
585 |
|
MMR |
20170710 |
|
notation |
C552428 |
|
prefLabel |
cabazitaxel |
|
SC |
1 |
|
Scope Statement |
an antineoplastic agent; structure in first source |
|
SRC |
Nat Rev Drug Discov 2010 Sep;9(9):677-8 |
|
TERMUI |
T000928575 T778202 T788428 |
|
TH |
NLM (2012) USAN (19XX) INN (19XX) NLM (2010) FDA SRS (2015) NLM (2017) |
|
tui |
T109 T121 |
Create mapping